SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-17-189320
Filing Date
2017-05-31
Accepted
2017-05-31 16:24:30
Documents
6
Effectiveness Date
2017-05-31

Document Format Files

Seq Description Document Type Size
1 S-8 d514308ds8.htm S-8 54473
2 EX-5.1 d514308dex51.htm EX-5.1 12164
3 EX-23.1 d514308dex231.htm EX-23.1 1994
4 EX-99.1 d514308dex991.htm EX-99.1 127998
5 GRAPHIC g514308ex51pg1.jpg GRAPHIC 5211
6 GRAPHIC g514308ex51pg2.jpg GRAPHIC 3001
  Complete submission text file 0001193125-17-189320.txt   209330
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-218373 | Film No.: 17881357
SIC: 2834 Pharmaceutical Preparations